OOIR: Observatory of International Research

Papers

(The H4-Index of Annual Review of Pharmacology and Toxicology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Nanoparticle Toxicology	166
Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span	149
Arsenic: A Global Environmental Challenge	137
Preventing and Treating Anthracycline Cardiotoxicity: New Insights	78
Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges	77
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy	73
Thioredoxin Reductase Inhibition for Cancer Therapy	64
E-Cigarette Toxicology	59
A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer	57
TRP Channel Cooperation for Nociception: Therapeutic Opportunities	54
Antisense Drugs Make Sense for Neurological Diseases	53
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance	51
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors	51
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure	41
Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor	39
Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics	39
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders	38
Endocrine-Disrupting Chemicals and Child Health	37
Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease	37
Drugs That Regulate Local Cell Signaling: AKAP Targeting as a Therapeutic Option	37
Oxidative Stress and Metabolism: A Mechanistic Insight for Glyphosate Toxicology	36
Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases	35
Endocannabinoid-Based Therapies	34
Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics	34
Store-Operated Ca²⁺ Channels: Mechanism, Function, Pharmacology, and Therapeutic Targets	33

Neuropathic Pain: Mechanisms, Sex Differences, and Potential Therapies for a Global Problem	32
Pharmacologic Approach to Sinoatrial Node Dysfunction	32
Mechanism of Action of TiO₂: Recommendations to Reduce Uncertainties Related to Carcinogenic Potential	30
Drug Target Identification in Tissues by Thermal Proteome Profiling	29
Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond	29
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis	29